GlobeNewsWire
14 Oct 2026, 12:45 UTC · 2h ago
Impact · against what's priced in
Cannabix Technologies may see a valuation lift from the filing of a provisional patent for a rapid point-of-care THC breath test. This represents a potential expansion of the company's intellectual property moat for detection technology.
No priced-in read yet
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Cannabix Technologies has filed a provisional patent application in the US for a rapid point-of-care marijuana breath test to detect delta-9 THC.
Newannounces Oct. 14, 2026
So whatSuccessful conversion to a non-provisional patent could expand the company's IP moat and drive valuation multiples by 2027.
More positive than 94% of claims this week
Which stocks this story touches
Continue reading
5 related stories
The filing of a provisional US patent for a rapid point-of-care delta-9 THC breath test provides a potential path to expanded IP protections and future commercialization.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 79% of ticker scores this week
The company has filed a provisional patent for a novel rapid point-of-care marijuana breath test method.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Accesswire
2h ago
—
No price for BLO right now — the quote feed didn't answer.
BLO chart →
